News for 'Dr Reddy'

Shafali blasts 34-ball 69 as India rout Sri Lanka in 2nd T20I

Shafali blasts 34-ball 69 as India rout Sri Lanka in 2nd T20I

Rediff.com23 Dec 2025

Opener Shafali Verma smashed a quickfire half-century as India women thrashed Sri Lanka by seven wickets in the second T20 International in Visakhapatnam on Tuesday.

Pawar To Rupani: Leaders Who Died In Air Crashes

Pawar To Rupani: Leaders Who Died In Air Crashes

Rediff.com28 Jan 2026

Maharashtra Deputy Chief Minister Ajit Pawar and four others were killed after their aircraft crashed in Baramati on January 28, 2026. Here are 11 other prominent Indians who died in air crashes.

'India Should Move Quickly As Conditions Change'

'India Should Move Quickly As Conditions Change'

Rediff.com2 Jan 2026

'The real story of 2025 is that India officially stopped being a 'market of the future' and started acting as the world's primary economic engine.'

Can MFN Pricing Reshape India-US Pharma Equation?

Can MFN Pricing Reshape India-US Pharma Equation?

Rediff.com5 Jun 2025

US accounts for a large part of revenue for top Indian pharma companies like Gland Pharma (54 percent), Dr Reddy's (53 per cent), and Aurobindo Pharma (48 per cent).

'14+ Anti-Obesity Drugs In The Pipeline'

'14+ Anti-Obesity Drugs In The Pipeline'

Rediff.com13 Dec 2025

The semaglutide patent expiry next year could unleash a wave of generic versions from Indian drugmakers, with prices expected to go lower -- at least 80 per cent.

Tickets 'Gone in Minutes' After Kohli's Twin Tons

Tickets 'Gone in Minutes' After Kohli's Twin Tons

Rediff.com5 Dec 2025

'After Kohli's hundred at Ranchi, the second and third phases vanished in minutes. Nothing was left unsold.'

USFDA's new draft biosimilar rules to benefit Indian biotech cos

USFDA's new draft biosimilar rules to benefit Indian biotech cos

Rediff.com9 Nov 2025

The US Food and Drug Administration's (USFDA)'s new draft guidelines aimed at speeding up and reducing the cost of developing biosimilars - lower-priced, near-replicas of complex biologic medicines - could significantly benefit Indian biotech companies.

Celebrating India's World Champions!

Celebrating India's World Champions!

Rediff.com6 Jan 2026

India's World Cup winning captains -- Harmanpreet Kaur, Deepika T C and Rohit Sharma -- were honoured by the Reliance Foundation in Mumbai on Monday.

US WHO Exit Won't Impact India: Experts

US WHO Exit Won't Impact India: Experts

Rediff.com22 Jan 2025

'Both international cooperation and self-reliance will now acquire new purpose.'

AIADMK, BJP begin preliminary talks for 2026 TN polls

AIADMK, BJP begin preliminary talks for 2026 TN polls

Rediff.com23 Dec 2025

NDA constituents AIADMK and BJP have started preliminary discussions for the 2026 Tamil Nadu Assembly elections. Key leaders from both parties met to discuss strategies to defeat the DMK government and strengthen their alliance.

'The Key Is Talent, Technology, Trust'

'The Key Is Talent, Technology, Trust'

Rediff.com30 Dec 2025

'Our problem is not a budget deficit but a trust deficit. We need to trust our institutions and industries to innovate and lead. That is the way forward for India.'

Sensex down 122 points; Dr Reddy's up 3%

Sensex down 122 points; Dr Reddy's up 3%

Rediff.com13 Jun 2007

NSE Nifty ended at 4,113, down 42 points.

Don't judge people by caste, wealth or language: Bhagwat

Don't judge people by caste, wealth or language: Bhagwat

Rediff.com31 Dec 2025

RSS chief Mohan Bhagwat emphasized the importance of social harmony, environmental responsibility, and national unity, urging people to rise above divisions and work collectively for the betterment of society and the nation.

Sensex gains 2 points; Dr Reddy's up 3%

Sensex gains 2 points; Dr Reddy's up 3%

Rediff.com8 Oct 2003

It has currently pared gains on weakness in select stocks, and is now up 22 points at 4,655. The Nifty has advanced 10 points to 1,488.

Pharma stocks slide as US headwinds hurt

Pharma stocks slide as US headwinds hurt

Rediff.com16 Sep 2025

Concerns over weakening demand for Indian pharmaceutical (pharma) drugs in the US - their largest export market - have weighed heavily on investor sentiment this year. While the Nifty 50 has gained 6.02 per cent year - to - date (as on September 15), the Nifty Pharma index has declined 5.18 per cent, National Stock Exchange data shows.

Trump's 100% tariff on pharma unlikely to hurt domestic industry: Experts

Trump's 100% tariff on pharma unlikely to hurt domestic industry: Experts

Rediff.com26 Sep 2025

Indian Pharmaceutical Alliance (IPA) on Friday said US President Donald Trump's move to impose 100 per cent import tariffs on pharmaceutical drugs from October 1 will impact only patented and branded products, not generic medicines.

From one Radhakrishnan to another: Congress's reminder to VP-elect

From one Radhakrishnan to another: Congress's reminder to VP-elect

Rediff.com10 Sep 2025

The Congress party extended best wishes to the newly-elected Vice President of India, C P Radhakrishnan, while also recalling the words of the first Vice President, Sarvepalli Radhakrishnan, on the importance of a strong opposition in a democracy.

Factors that will drive the markets this week

Factors that will drive the markets this week

Rediff.com21 Jul 2025

Trading sentiment in the stock market this week will be guided by quarterly earning announcements from blue-chips such as Infosys and Bajaj Finance, the outcome of India-US trade talks and global cues, analysts said. Markets may on Monday react to the quarterly results of three heavyweights - Reliance Industries, HDFC Bank and ICICI Bank, an expert said.

'You Can't Be Madhuri Dixit Anywhere'

'You Can't Be Madhuri Dixit Anywhere'

Rediff.com3 Dec 2025

'One day my neighbour in Denver called me and said, "I think somebody is casing your house. So should I call the cops?"... they were scared that people case your house and then rob it.' 'And I said, "no, no, no. It's just that I am an actress".'

Indian Pharma Majors Ready With Weight Loss Drugs

Indian Pharma Majors Ready With Weight Loss Drugs

Rediff.com12 Aug 2025

Prices for Indian consumers are expected to come down significantly from the current Rs 17,000-Rs 26,000 monthly.

Can G V Prasad fill in Anji Reddy's shoes?

Can G V Prasad fill in Anji Reddy's shoes?

Rediff.com5 Apr 2013

G V Prasad is elevated as chairman of Dr Reddy's Laboratories, a position held by the late K Anji Reddy, and he has big shoes to fill.

'Some are doing too much': Shivakumar on Bengaluru infra criticism

'Some are doing too much': Shivakumar on Bengaluru infra criticism

Rediff.com19 Oct 2025

Karnataka Deputy Chief Minister D K Shivakumar responds to criticism regarding Bengaluru's infrastructure, while industry leaders and opposition members voice their concerns.

9 PIOs in fray for US Congress, 6 expected to win

9 PIOs in fray for US Congress, 6 expected to win

Rediff.com5 Nov 2024

Nine Indian Americans are running for the US House of Representatives, which includes a re-election bid by six of them while three are making their maiden foray into Congressional politics.

Am an uncompromising nationalist, says V-P elect Radhakrishnan

Am an uncompromising nationalist, says V-P elect Radhakrishnan

Rediff.com10 Sep 2025

Maharashtra Governor C P Radhakrishnan reflects on his tenure as he prepares to move to Delhi as the next Vice President of India, calling it the happiest period in his public life.

When A Vice President Resigned For The First Time

When A Vice President Resigned For The First Time

Rediff.com22 Jul 2025

Vice President V V Giri's resignation in 1969 triggered political upheavals that saw the ruling party defy its own presidential nominee, the expulsion of a sitting prime minister by her party president, and a historic split in the Indian National Congress, recounts Utkarsh Mishra.

'Rahul Can't Play Victim All The Time'

'Rahul Can't Play Victim All The Time'

Rediff.com17 Nov 2025

'Rahul Gandhi's problem is that he doesn't think big.' 'He looks more like an activist, while politics is like a game of chess. You attack and then defend and have a game-plan.'

Dr Reddy's: From Rs 25 lakh to Rs 5,800 crore

Dr Reddy's: From Rs 25 lakh to Rs 5,800 crore

Rediff.com12 Jun 2007

K Anji Reddy from a small village near Vijaywada, quit his job with the government-owned Indian Drugs and Pharmaceuticals Limited in 1974 to set up his own company. The rest is history.

Reddy's get US FDA nod for drug

Reddy's get US FDA nod for drug

Rediff.com10 Jul 2003

Ranbaxy, Reddy's vie for US cholesterol drug mart

Ranbaxy, Reddy's vie for US cholesterol drug mart

Rediff.com3 May 2006

Simvastatin goes off patent in late June; Ranbaxy gets 180-day exclusivity period; Dr Reddy's-Merck will be third player.

Anji Reddy, healer extraordinaire

Anji Reddy, healer extraordinaire

Rediff.com19 Mar 2013

Dr Reddy, an innovative technocrat par excellence, led from the front the countless initiatives of his famed laboratory in discovering many effective, affordable, cures for the numerous ailments of mankind, writes Shreekant Sambrani.

Telugu poet C Narayana Reddy passes away

Telugu poet C Narayana Reddy passes away

Rediff.com12 Jun 2017

'In his demise, the world of Telugu language and literature has lost a bright star. The void caused by his loss can never be filled.'

Reddy's, Ranbaxy not to go all out for Merck

Reddy's, Ranbaxy not to go all out for Merck

Rediff.com12 Mar 2007

With the bidding for the generics business of Merck set to begin from Monday, domestic pharmaceutical companies in the fray, Ranbaxy Laboratories and Dr Reddy's Laboratories, are unlikely to go for an all-out bidding war.

C P Radhakrishnan sworn-in as Vice President, Dhankhar attends ceremony

C P Radhakrishnan sworn-in as Vice President, Dhankhar attends ceremony

Rediff.com12 Sep 2025

Chandrapuram Ponnusamy Radhakrishnan was sworn in as the 15th Vice President of India, succeeding Jagdeep Dhankhar.

'Dr YSR was a very devoted Christian'

'Dr YSR was a very devoted Christian'

Rediff.com7 Sep 2009

'There is no doubt he is with the Lord in heaven. He loved people and people poured their love on him. It was the people's love that got him elected as chief minister for a second term.'

Highest Selling New Drug In India Is...

Highest Selling New Drug In India Is...

Rediff.com11 Feb 2025

Enhertu currently costs around Rs 1.6 lakh per 100-milligram injection.

Sonia monitoring Reddy search operation

Sonia monitoring Reddy search operation

Rediff.com2 Sep 2009

She met with Defence Minister A K Antony, Finance Minister Pranab Mukherjee, her political secretary Ahmed Patel and others on Wednesday evening to take stock of the situation.

Reddy's files with US FDA for generic Olanzapine

Reddy's files with US FDA for generic Olanzapine

Rediff.com11 Mar 2003

Drugmaker Dr Reddy's Laboratories has filed an application with the US Food and Drug Administration to market a generic form of Eli Lilly's schizophrenia drug Olanzapine in the US

Can Dehydration Cause Muscle Cramps?

Can Dehydration Cause Muscle Cramps?

Rediff.com18 Jun 2025

rediffGURU Dr Shakeeb Ahmed Khan, a physiotherapist with 13 years of experience, explains how you can prevent injuries and heal from physical pain.

Pricing challenge in US biz, rich valuations may weigh on pharma stocks

Pricing challenge in US biz, rich valuations may weigh on pharma stocks

Rediff.com11 Jun 2024

The tailwind of low price erosion in the US generics market, seen by domestic pharmaceutical companies in calendar year 2023 (CY23), may be reversing slowly, caution analysts. According to the latest data from US-based Centers for Medicare and Medicaid Services (CMMS), price erosion in calendar year 2024 (CY24) on a year-to-date (YTD) basis stood at a high of 15 per cent in the oral solid dosage (OSD) segment compared to a low of 1 per cent in CY23. This erosion, according to a report by Antique Stock Broking, was the highest in the last three years.

Why John Abraham Met Jaishankar

Why John Abraham Met Jaishankar

Rediff.com14 Mar 2025

Dr Jaishankar meets up with movie star John Abraham, who plays J P Singh, currently India's ambassador to Israel, in The Diplomat.